a peculiar type of IgAGN. Moreover, interstitial expression of TGF-b, ET-1 and c-fos in biopsies with Background. Among our cases of IgA glomerulonephritis (IgAGN ), 10% show necrotizing/extracapil-glomerular active lesions but complete absence of interstitial fibrosis may potentially represent a signal lary lesions involving a small percentage of glomeruli and associated with a certain degree of inflammation of activation of mechanisms that induce and amplify the damage leading to further progression of the in absence of glomerular and interstitial scarring. In our experience, also in repeat biopsies, these cases of disease.
progression of glomerulonephritis, aim of the study Introduction was to examine their expression in renal biopsies of primary IgAGN with necrotizing/crescentic lesions in Among the possible mechanisms involved in the procomplete absence of interstitial fibrosis. To obtain cess of glomerular and interstitial scarring, TGF-b is information about the mitogenic effect of ET-1, the now recognized as crucial, especially because of its expression of c-fos, whose upregulation by ET-1 has ability to promote synthesis and deposition of extrabeen established in culture, was also studied. cellular matrix [1] [2] [3] [4] . Moreover, recent culture studies Methods. Eighteen renal biopsies of patients with nechave shown that TGF-b, among its various and comrotizing/crescentic IgAGN were examined by immunoplex properties, can also stimulate the synthesis of histochemistry with antibodies against TGF-b, ET-1 endothelin-1 ( ET-l ) [5] , a multifunctional peptide and c-fos. The results were compared with those potentially implicated in the progression of renal obtained on 22 cases of IgAGN characterized only by damage by its vasoconstrictive, chemotactic, and pure mesangial proliferation and 25 IgAGN biopsies mitogenic effects [6] [7] [8] . The latter is mainly mediated with advanced, not active, glomerulointerstitial lesions.
by activation of phospholipase C and increase in c-fos Results. In necrotizing/crescentic IgAGN glomerular proto-oncogene expression, as demonstrated on renal TGF-b appeared more positive than in cases charactercultured cells [9, 10] . ized only by pure mesangial proliferation and was Primary IgA glomerulonephritis (IgAGN, Berger's especially expressed on cellular crescents. In the interdisease) is a very common chronic renal disease [11], stitium, TGF-b, ET-1 and c-fos were expressed by which rate of progression to the end-stage kidney is infiltrating leukocytes, tubules, and small vessels. This about 30% of cases [12] . By light-microscopy the most positivity, although similar as localization, was less common features are mesangial expansion and prolifdiffuse than in biopsies with advanced interstitial eration, but a great variety of lesions, both glomerular damage, but significantly greater than in cases with and interstitial, can be observed ranging from pictures pure mesangial proliferation.
of only mild mesangial proliferation to cases with Conclusions. Positivity of TGF-b on cellular crescents marked glomerular and interstitial damage [12, 13] . is similar to that observed from other authors in Whether morphological differences are expression of different types of necrotizing/crescentic human glomthe time of biopsy intervention or of different types of erulonephritis and supports our hypothesis that this is disease is difficult to establish, also because the disease has generally an indolent course, making it difficult to primary IgAGN, the presence of necrotizing/extra- peculiar lesions on the progression of the disease, we
Specificity of labelling was demonstrated by the lack of compared this group of biopsies to cases characterized staining after substitution of phosphate-buffered saline (PBS) only by pure mesangial proliferation and to cases with for the primary antibody. marked glomerular and interstitial involvement, but absence of active necrotizing/crescentic lesions.
Quantitative evaluation
All peroxidase-stained sections had five or more glomeruli
Subjects and methods
and were evaluated blind by two independent observers without any histological or clinical information. Minor
Patients differences were subsequently resolved by conference.
Interstitial infiltrating cells were counted in 10 consecutive Sixty-five patients (41 males and 24 females), with a mean high-power fields (400×), avoiding glomeruli and large vesage of 35.8±14.8 years (ranging from 18 to 80), with sels; the results were expressed as 'number of positive cells immunohistological evidence of IgAGN, were studied. per square millimeter'. Intraglomerular and interstitial Secondary IgAGNs (i.e. Henoch-Schö nlein nephritis, hepatic staining of TGF-b, ET-1, and c-fos were scored semidiseases, coeliac disease, etc.) were excluded on the basis of quantitatively, on a 4-point scale: no staining, 0; mild and clinical and laboratory data. The patients, selected on the focal staining, 1; moderate and more diffuse staining, 2; basis of morphological features, were divided in three groups: intense and diffuse staining, 3. group 1 (22 patients 
Group 3.
While global sclerotic glomeruli were negative Group 3. These biopsies were grouped because of the presence of marked glomerular and interstitial lesions. for every markers studied, the remnant glomeruli in group 3 biopsies showed intense and diffuse positivity Global glomerular sclerosis was found in 37.9±17.9% of glomeruli, whereas remnant glomeruli showed a for TGF-b (group 3 vs group 1; P=0.001, group 3 vs group 2; P=0.8) (Figure 1d ), whereas ET-1 and c-fos mesangial proliferation similar to that found in groups 1 and 2 (+/++). Fibrous crescents were detected in expression was mild (group 3 vs group 2 and group 1; P>0.05). Interstitial TGF-b was very intense, invol-10.8±15.0% of glomeruli. Interstitial fibrotic and inflammatory lesions were intense: interstitial leuko-ving most of interstitial leukocytes ( Figure 2d) 297 ( Figures 3d, 4d ) . vs group 2). Immunohistocitemical features. Immunohistochemical results are shown in Table 1 .
Discussion
Normal kidneys and group 1 biopsies. The 10 control biopsies and group 1 biopsies showed similar results: TGF-b was positive in rare glomerular cells (Figure Our data show a good association between morphological and immunohistochemical features. Biopsies of 1a) and negative in the interstitium ( Figure 2a) . ET-1 and c-fos were only observed on rare small vessels group 1, with pure mesangial nephropathy, showed in fact a glomerular and interstitial negativity or a very (Figure 3a, 4a) , whereas glomeruli, tubules, and interstitial cells were negative.
mild positivity for TGF-b, ET-1 and c-fos. On the contrary, group 3 biopsies were characterized not only Group 2. In necrotizing/crescentic IgAGN we observed an intense glomerular positivity of TGFb (group 2 vs by marked and diffuse glomerular and interstitial positivity for TGF-b, but also by intense interstitial expresgroup 1; P=0.004), especially localized on the cellular crescents and expressed by all cell types ( Figure 1 b,c) . sion of ET-1 and c-fos. Although a paper has shown a downregulation of TGF-b in IgA nephropathy [18] , Glomerular ET-1 and c-fos were scanty or not expressed (group 2 vs group 1; P=0.2).
our results seem to suggest the involvement of these factors in the worsening of IgAGN, in agreement with In the interstitium TGF-b was positive in about 20% of interstitial infiltrating leukocytes (40.2±10.6+ other recent studies [19] [20] [21] [22] [23] . Indeed, TGF-b is a growth factor now widely recognized as crucial in the cells/mm2) (Figure 2 b,c) and on some proximal and distal tubules (group 2 vs group 1; P=0.04). ET-1 and process of renal scarring, especially by its property of regulating cell turnover and matrix metabolism. In c-fos were present on rare tubules (group 2 vs group 1; P>0.05), some small vessels (group 2 vs group 1; particular, it increases the deposition of extracellular matrix either stimulating new matrix synthesis or that necrotizing/crescentic IgAGN is comparable not only morphologically, but possibly also pathoinhibiting matrix-degrading enzymes [1] [2] [3] [4] .
Although culture studies have demonstrated that genetically, to other necrotizing/crescentic glomerular diseases. TGF-b, added to mesangial cells in culture, can markedly increase their production of ET-1 and their prolifInterestingly, an increased interstitial expression of TGF-b, ET-1 and c-fos was shown by group 2 biopsies. erating activity [5, 9] , we observed, in comparison with the diffuse staining for TGF-b, only a mild expression All the factors stained positively about 20% of interstitial inflammatory cells and several tubules and ET-l of glomerular ET-1 in remnant glomeruli of group 3 biopsies. Considering also that TGF-b is not the unique and c-fos were also expressed by some small vessels.
Since it is well known that tubulointerstitial damage factor involved in ET-1 regulation, this feature was consistent with the morphological finding of a moder-plays a key-role in the progression of glomerulonephritis [28] , the tubulointerstitial positivity of TGFate mesangial proliferation and with the mild glomerular immunostaining for c-fos shown by these cases.
b, ET-1, and c-fos in these biopsies, in which interstitial fibrosis is totally absent, could be a signal of activation In fact, among its various and potentially damaging properties, ET-1 is also able to induce mitogenesis [9] , of potential mechanisms of worsening. It is worth stressing that patients selected for this study had a effect that appear mediated by activation of phospholipase C and enhanced expression of some proto-comparable pre-biopsy follow-up, suggesting that morphological and immunohistochemical differences are oncogenes, mainly c-fos [10] . We actually observed in all biopsies examined a strict correlation between the not a consequence of early or late biopsy time, but probably are related to different courses of the disease. immunohistochemical positivity of ET-1 and that of cfos, both at glomerular and at interstitial levels. Given Taken together, our data seem to suggest that necrotizing/crescentic IgAGN is a particular type of Berger's the complexity of the in vivo situation, we do not want to assert that all the c-fos expression recognizes ET-1 disease, in which TGF-b and ET-1 may play an important role. Moreover, ET-1 has not only as unique stimulus, but our results seem to support in human IgAGN the data obtained in culture about at mitogenic, chemotactic, and vasoconstrictive properties, but it can also promote the expression of tranleast one of the pathways through which ET-1 exerts its mitogenic effect.
scripts for several growth factors [29, 30] , and among them, for instance, TGF-b [9] , therefore inducing a About 10% of cases of IgAGN show a picture of focal and segmental necrotizing/crescentic nephritis. vicious cycle that might amplify the damage. We have recently described in 26 biopsies with these lesions the presence of peculiar immunohistochemical References features, such as the expression of intraglomerular VCAM-1 (vascular cell adhesion molecule-1) and an
